| Primary |
| Renal Transplant |
37.1% |
| Bone Marrow Transplant |
6.5% |
| Cord Blood Transplant Therapy |
6.4% |
| Hypertension |
5.8% |
| Heart Transplant |
5.8% |
| Liver Transplant |
5.3% |
| Colitis Ulcerative |
5.2% |
| Stem Cell Transplant |
4.3% |
| Prophylaxis Against Graft Versus Host Disease |
3.5% |
| Lung Transplant |
3.3% |
| Aplastic Anaemia |
3.1% |
| Prophylaxis |
2.2% |
| Psoriasis |
2.1% |
| Graft Versus Host Disease |
2.0% |
| Allogenic Bone Marrow Transplantation Therapy |
1.7% |
| Nephrotic Syndrome |
1.2% |
| Prophylaxis Against Transplant Rejection |
1.2% |
| Immunosuppression |
1.2% |
| Pain |
1.2% |
| Rheumatoid Arthritis |
1.0% |
|
| Vomiting |
12.3% |
| Renal Failure |
8.4% |
| Transplant Rejection |
7.5% |
| Pyrexia |
7.2% |
| Renal Impairment |
6.3% |
| Death |
5.5% |
| Weight Increased |
5.5% |
| White Blood Cell Count Increased |
5.5% |
| White Blood Cell Count Decreased |
4.8% |
| Tremor |
4.3% |
| Urinary Tract Infection |
4.1% |
| Pneumonia |
3.8% |
| Renal Failure Acute |
3.6% |
| Sepsis |
3.6% |
| Respiratory Failure |
3.1% |
| Rhabdomyolysis |
3.1% |
| Thrombotic Microangiopathy |
3.1% |
| Visual Acuity Reduced |
2.9% |
| Hypertensive Crisis |
2.6% |
| Lymphocele |
2.6% |
|
| Secondary |
| Renal Transplant |
31.7% |
| Stem Cell Transplant |
6.6% |
| Prophylaxis |
6.3% |
| Hypertension |
6.0% |
| Lung Transplant |
5.6% |
| Heart Transplant |
5.1% |
| Juvenile Arthritis |
4.3% |
| Liver Transplant |
4.1% |
| Prophylaxis Against Graft Versus Host Disease |
3.7% |
| Drug Use For Unknown Indication |
3.6% |
| Cord Blood Transplant Therapy |
3.2% |
| Bone Marrow Transplant |
3.0% |
| Graft Versus Host Disease |
2.7% |
| Immunosuppression |
2.6% |
| Allogenic Bone Marrow Transplantation Therapy |
2.4% |
| Infection Prophylaxis |
2.2% |
| Product Used For Unknown Indication |
2.2% |
| Prophylaxis Against Transplant Rejection |
2.0% |
| Aplastic Anaemia |
1.7% |
| Pain |
1.0% |
|
| Vomiting |
13.8% |
| Renal Failure |
11.4% |
| Renal Impairment |
6.8% |
| Thrombotic Microangiopathy |
6.6% |
| Toxic Encephalopathy |
5.8% |
| White Blood Cell Count Increased |
5.2% |
| Pneumonia |
4.8% |
| Pyrexia |
4.8% |
| Urinary Tract Infection |
4.8% |
| Venoocclusive Liver Disease |
4.4% |
| White Blood Cell Count Decreased |
4.4% |
| Respiratory Failure |
3.6% |
| Weight Increased |
3.6% |
| Nephropathy Toxic |
3.2% |
| Sepsis |
3.2% |
| Wound Dehiscence |
3.0% |
| Histiocytosis Haematophagic |
2.8% |
| Tremor |
2.8% |
| Pleural Effusion |
2.6% |
| Renal Failure Acute |
2.4% |
|
| Concomitant |
| Renal Transplant |
31.6% |
| Product Used For Unknown Indication |
14.9% |
| Drug Use For Unknown Indication |
9.6% |
| Aplastic Anaemia |
5.9% |
| Hypertension |
5.0% |
| Immunosuppression |
4.1% |
| Prophylaxis |
3.4% |
| Prophylaxis Against Transplant Rejection |
3.4% |
| Infection Prophylaxis |
3.2% |
| Prophylaxis Against Graft Versus Host Disease |
2.9% |
| Packed Red Blood Cell Transfusion |
2.6% |
| Platelet Transfusion |
2.6% |
| Rheumatoid Arthritis |
2.5% |
| Stem Cell Transplant |
1.7% |
| Acute Myeloid Leukaemia |
1.5% |
| Allogenic Bone Marrow Transplantation Therapy |
1.2% |
| Acute Lymphocytic Leukaemia |
1.1% |
| Graft Versus Host Disease |
1.0% |
| Angioimmunoblastic T-cell Lymphoma |
1.0% |
| Colitis Ulcerative |
0.9% |
|
| Sepsis |
17.6% |
| Renal Failure |
9.7% |
| Pyrexia |
7.9% |
| Vomiting |
7.1% |
| Urine Output Decreased |
4.9% |
| Weight Decreased |
4.9% |
| Weight Increased |
4.9% |
| Death |
4.5% |
| Kidney Transplant Rejection |
4.1% |
| Residual Urine |
4.1% |
| Rhabdomyolysis |
3.7% |
| Surgery |
3.4% |
| Visual Impairment |
3.4% |
| Acute Graft Versus Host Disease In Intestine |
3.0% |
| Diarrhoea |
3.0% |
| Nephrogenic Systemic Fibrosis |
3.0% |
| Pancreatitis Acute |
3.0% |
| Deep Vein Thrombosis |
2.6% |
| Hypoglycaemia |
2.6% |
| Pneumonia |
2.6% |
|
| Interacting |
| Hypertension |
20.2% |
| Renal Transplant |
14.5% |
| Bone Marrow Failure |
9.8% |
| Heart Transplant |
7.5% |
| Glomerulonephritis |
4.6% |
| Hyperlipidaemia |
4.6% |
| Hypercholesterolaemia |
4.0% |
| Hypothyroidism |
4.0% |
| Colitis Ulcerative |
3.5% |
| Clostridium Difficile Colitis |
2.9% |
| Drug Use For Unknown Indication |
2.9% |
| Metabolic Acidosis |
2.9% |
| Aortic Stenosis |
2.3% |
| Atrial Fibrillation |
2.3% |
| Gastric Ulcer |
2.3% |
| Graft Versus Host Disease |
2.3% |
| Infection Prophylaxis |
2.3% |
| Myocardial Infarction |
2.3% |
| Prophylaxis |
2.3% |
| Renal Failure Chronic |
2.3% |
|
| Vomiting |
22.6% |
| Rhabdomyolysis |
13.2% |
| Drug Interaction |
9.4% |
| Tremor |
7.5% |
| Immunosuppressant Drug Level Decreased |
5.7% |
| Mesenteric Vein Thrombosis |
5.7% |
| Headache |
3.8% |
| Myalgia |
3.8% |
| Toxicity To Various Agents |
3.8% |
| Urinary Tract Infection |
3.8% |
| Weight Decreased |
3.8% |
| Aspartate Aminotransferase Increased |
1.9% |
| Clonic Convulsion |
1.9% |
| Drug Level Increased |
1.9% |
| Electrocardiogram Qt Prolonged |
1.9% |
| Haemolysis |
1.9% |
| Leukoencephalopathy |
1.9% |
| Liver Function Test Abnormal |
1.9% |
| Myelodysplastic Syndrome |
1.9% |
| Psychotic Disorder |
1.9% |
|
